ArticleScientific reports2024

Magnetic resonance imaging of tumor response to stroma-modifying pegvorhyaluronidase alpha (PEGPH20) therapy in early-phase clinical trials.

Andrés M Arias-Lorza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.